{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:33:00Z","timestamp":1778682780439,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.xphs.2025.02.003","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T18:52:13Z","timestamp":1739299933000},"page":"103697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Possible applications of the Polli dissolution mechanism: A case study using molecular dynamics simulation of Bupivacaine"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4114-5236","authenticated-orcid":false,"given":"Peter J.","family":"Skrdla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Browning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiva","family":"Sekharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Gavartin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2025.02.003_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.07.011","article-title":"A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system","volume":"321","author":"Dokoumetzidis","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2025.02.003_bib0002","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jconrel.2015.09.052","article-title":"In vitro-in vivo correlation for complex non-oral drug products: where do we stand?","volume":"219","author":"Shen","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2025.02.003_bib0003","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12272-013-0105-7","article-title":"Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia","volume":"36","author":"Park","year":"2013","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.xphs.2025.02.003_bib0004","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2025.02.003_bib0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1011984216775","article-title":"Dissolution testing as a prognostic tool for oral absorption: immediate release dosage forms","volume":"15","author":"Dressman","year":"1998","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2025.02.003_bib0006","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.02.003_bib0007","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1208\/s12248-010-9203-3","article-title":"The use of biorelevant dissolution media to forecast the in vivo performance of a drug","volume":"12","author":"Klein","year":"2010","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2025.02.003_bib0008","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0169-409X(00)00130-7","article-title":"Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract","volume":"46","author":"H\u00f6rter","year":"2001","journal-title":"Adv Drug Delivery Rev"},{"key":"10.1016\/j.xphs.2025.02.003_bib0009","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.xphs.2017.10.019","article-title":"Industry's view on using quality control, biorelevant, and clinically relevant dissolution tests for pharmaceutical development, registration, and commercialization","volume":"1","author":"Grady","year":"2018","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.02.003_bib0010","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1021\/ja02086a003","article-title":"The rate of solution of solid substances in their own solutions","volume":"19","author":"Noyes","year":"1897","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.xphs.2025.02.003_bib0011","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpharm.2013.04.044","article-title":"Mathematical modeling of drug dissolution","volume":"453","author":"Siepmann","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2025.02.003_bib0012","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5599\/admet.2.1.31","article-title":"Phosphate precipitates and water-soluble aggregates in re-analyzed solubility-pH data of twenty-five basic drugs","volume":"2","author":"Avdeef","year":"2014","journal-title":"ADMET DMPK"},{"key":"10.1016\/j.xphs.2025.02.003_bib0013","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1021\/acs.molpharmaceut.3c00429","article-title":"Drug aggregation of sparingly-soluble ionizable drugs: molecular dynamics simulations of papaverine and prostaglandin F2\u03b1","volume":"20","author":"Skrdla","year":"2023","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2025.02.003_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12248-022-00765-3","article-title":"A simple one-parameter percent dissolved versus time dissolution equation that accommodates sink and non-sink conditions via drug solubility and dissolution volume","volume":"25","author":"Polli","year":"2023","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2025.02.003_bib0015","series-title":"Schr\u00f6dinger Materials Science Suite, Version 23-4","year":"2019"},{"key":"10.1016\/j.xphs.2025.02.003_bib0016","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1021\/cg200855p","article-title":"Predictive modeling of supersaturation-dependent crystal shapes","volume":"12","author":"Lovette","year":"2012","journal-title":"Cryst Growth Des"},{"key":"10.1016\/j.xphs.2025.02.003_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123890","article-title":"Thermodynamic solubility measurement without chemical analysis","volume":"653","author":"Hokkala","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2025.02.003_bib0018","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jpba.2007.06.012","article-title":"A simple model for complex dissolution kinetics: a case study of norfloxacin","volume":"45","author":"Skrdla","year":"2007","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2025.02.003_bib0019","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1016\/j.xphs.2020.04.023","article-title":"Biorelevant two-stage in vitro testing for rDCS classification and in PBPK modeling - case example Ritonavir","volume":"109","author":"Fiolka","year":"2020","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.02.003_bib0020","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1039\/C7BM00052A","article-title":"Glutathione-responsive paclitaxel dimer nanovesicles with high drug content","volume":"5","author":"Pei","year":"2017","journal-title":"Biomater Sci"},{"key":"10.1016\/j.xphs.2025.02.003_bib0021","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0378-5173(95)04220-2","article-title":"Investigation of drug self-association in aqueous solution using calorimetry, conductivity and osmometry","volume":"130","author":"Zhu","year":"1996","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2025.02.003_bib0022","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0168-3659(93)90007-R","article-title":"pH-dependent solubility and dissolution of bupivacaine and its relevance to the formulation of a controlled release system","volume":"23","author":"Shah","year":"1993","journal-title":"J Control Release"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925001066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925001066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T12:12:38Z","timestamp":1742299958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925001066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0022354925001066"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.02.003","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv-2024-9xw6v","asserted-by":"object"}]},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Possible applications of the Polli dissolution mechanism: A case study using molecular dynamics simulation of Bupivacaine","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103697"}}